Search | Pikumil

Sarthak Jain added blog Health
2026-07-03 09:20:48 -

The Targeted Approach: How Biologic Arthritis Therapies and Disease-modifying Antirheumatic Drugs (DMARDs) Are Redefining Remission in Rheumatoid Arthritis
The advent of Biologic arthritis therapies marked a paradigm shift in the treatment of rheumatoid arthritis. For the first time, therapies were developed that could precisely target and neutralize specific molecules in the inflammatory cascade that drives the disease. This targeted approach, often used in combination with Disease-modifying antirheumatic drugs (DMARDs) , has...

0 Comments 0 Shares 331 Views 0 Reviews

Please log in to like, share and comment!
Priti Mrfr added blog Health
2026-08-13 09:01:39 -

Arthritis Monoclonal Antibodies Market – Biologic Therapies Transforming Autoimmune Joint Disease Treatment
Market Overview The arthritis monoclonal antibodies market continues expanding as rheumatologists increasingly prescribe biologic therapies for patients with rheumatoid arthritis and other autoimmune joint conditions who fail conventional disease-modifying antirheumatic drugs. Monoclonal antibody therapies target specific inflammatory pathways such as tumor necrosis factor and interleukin...

0 Comments 0 Shares 359 Views 0 Reviews

Please log in to like, share and comment!
Shiv Mehara added blog Health
2025-11-24 11:49:40 -

Osteoarthritis Drugs Market
Introspective Market Research (IMR) today unveiled a critical new report detailing the accelerated evolution of the Global Osteoarthritis (OA) Drugs Market. The market, valued at USD 4.70 Billion in 2023, is forecast to more than double, reaching USD 10.38 Billion by 2032, demonstrating a high-velocity Compound Annual Growth Rate (CAGR) of 9.2% during the 2024–2032 forecast period. This...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!